Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis.
Mucha L, Hoppe B, Silber A, Wang Z, Miyasato G, Skaar JR, Langman C.
Mucha L, et al. Among authors: silber a.
J Manag Care Spec Pharm. 2022 Mar;28(3):316-323. doi: 10.18553/jmcp.2022.28.3.316.
J Manag Care Spec Pharm. 2022.
PMID: 35199581
Free PMC article.
BACKGROUND: Primary hyperoxaluria (PH) is a family of rare, life-threatening genetic liver disorders characterized by elevated production and excretion of oxalate. ...OBJECTIVE: To characterize the clinical and economic costs, as well as health care resource utilization (H …
BACKGROUND: Primary hyperoxaluria (PH) is a family of rare, life-threatening genetic liver disorders characterized by elevated produc …